TissGDB
Tissglogo

Home

Download

 Statistics

 Landscape

Help

Contact

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

bullet point

TissGeneSummary

bullet point

TissGeneExp

bullet point

TissGene-miRNA

bullet point

TissGeneMut: TissGeneSNV, TissGeneCNV, and TissGeneFusions

bullet point

TissGeneNet

bullet point

TissGeneProg

bullet point

TissGeneClin: TissGeneDrug and TissGeneDisease

TissGeneSummary for MAGEA3
check button Gene summary
Basic gene informationGene symbolMAGEA3
Gene namemelanoma antigen family A, 3
SynonymsCT1.3|HIP8|HYPD|MAGE3|MAGEA6
CytomapUCSC genome browser: Xq28
Type of geneprotein-coding
RefGenesNM_005362.3,
DescriptionMAGE-3 antigenantigen MZ2-Dcancer/testis antigen 1.3cancer/testis antigen family 1, member 3melanoma-associated antigen 3
Modification date20141207
dbXrefs MIM : 300174
HGNC : HGNC
Ensembl : ENSG00000221867
HPRD : 02166
Vega : OTTHUMG00000022640
ProteinUniProt:
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_MAGEA3
BioGPS: 4102
PathwayNCI Pathway Interaction Database: MAGEA3
KEGG: MAGEA3
REACTOME: MAGEA3
Pathway Commons: MAGEA3
ContextiHOP: MAGEA3
ligand binding site mutation search in PubMed: MAGEA3
UCL Cancer Institute: MAGEA3
Assigned class in TissGDB*B
Included tissue-specific gene expression resourcesHPA,TiGER,GTEx
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx)SkinTestis
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA)SKCMTGCT
Reference showing the relevant tissue of MAGEA3
Description by TissGene annotations
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C.

check button Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO termPubMed ID


Top
TissGeneExp for MAGEA3

check button Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
gene exp


check button Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01)
gene isoform exp


check button Gene expressions across normal tissues of GTEx data
(GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct)
- Here, we shows the matched tissue types only among our 28 cancer types.
normal gene exp


check button Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
DEG exp

- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05)
Cancer typeMean(exp) in tumorMean(exp) in matched normalLog2FCP-val.FDR
LUSC2.751348205-1.1598125793.9111607842.40E-087.24E-08
LUAD1.109719334-1.2996185972.4093379312.28E-056.35E-05
LIHC2.578798989-0.7866230113.3654224.39E-062.04E-05
HNSC3.661522943-0.5723933364.2339162791.55E-061.11E-05
BLCA3.6402721470.1130353053.5272368420.01060.0471488
ESCA4.296836262-0.7564728295.0533090910.002220.023959034
STAD0.626690239-1.4753410112.102031250.0009760.005189182
BRCA-0.124794519-1.3464024141.2216078955.72E-050.000130892


Top
TissGene-miRNA for MAGEA3

check button Significantly anti-correlated miRNAs of TissGene across 28 cancer types
(Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016)
(TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21)
(TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16)
(Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25))
Cancer typemiRNA idmiRNA accessionP-val.Coeff.# samples


Top
TissGeneMut for MAGEA3
TissGeneSNV for MAGEA3

check button nsSNV counts per each loci.
Different colors of circles represent different cancer types. Circle size denotes number of samples.
(TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25)

* Click on the image to enlarge it in a new window.
SNV lollipop
bullet point


check button Somatic nucleotide variants of TissGene across 28 cancer types
(X-axis: cancer type and Y-axis: % of mutated samples)
The numbers in parentheses are numbers of samples with mutation (nsSNVs).
(TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25)
SNV distribution

- nsSNVs sorted by frequency.
AAchangeCancer type# samples
p.D187NSKCM2
p.E219DCOAD1
p.Q194XKIRC1
p.S300FLUAD1
p.L175VHNSC1
p.F146LLUSC1
p.P99SSKCM1
p.E235KSKCM1
p.P78SSKCM1
p.P262ASKCM1
p.S81ILUAD1
p.E85QLUAD1
p.A179VTHYM1
p.E314KBRCA1
p.K123RSTAD1
p.G137WHNSC1
p.E313KSKCM1
p.E91XUCS1
p.H298RSTAD1
p.V161ISKCM1
p.R19*BRCA1
p.S157FSKCM1
p.S157FLUAD1
p.L239FPAAD1
p.H118NHNSC1
p.H298YCESC1
p.S226ICOAD1
p.E280*LUAD1
p.G94ESKCM1
p.V140IBRCA1
p.Q144KSTAD1
p.F119YSKCM1
p.E313VBLCA1
p.R125*UCEC1
p.V279ILUAD1
p.E93*LGG1
p.V251LLUSC1
p.P262LSKCM1
p.H118YSKCM1
p.Y84NHNSC1
p.G295RSKCM1
p.L182PSTAD1
p.E168*UCEC1
p.L256VSTAD1
p.V149ALGG1
p.D241EPAAD1
p.A210TUCEC1
p.E91*UCS1
p.R211KSKCM1
p.P303LSKCM1
p.L109HCESC1
p.S300FSKCM1
p.P129LSTAD1
p.I150MBLCA1
p.E134ASKCM1
p.D241NSKCM1
p.K220NTHYM1
p.P148LSKCM1
p.G141RCOAD1
p.P242SSKCM1
p.P275SSKCM1


Top
TissGeneCNV for MAGEA3

check button Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples)
(TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16)
CNV


Top
TissGeneFusions for MAGEA3

check button Fusion genes including TissGene
(ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01)
DatabaseSrcCancer typeSampleFusion geneORF5'-gene BP3'-gene BP


Top
TissGeneNet for MAGEA3

check button Co-expressed gene networks based on protein-protein interaction data (CePIN)
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(PINA2 ppi data)
BRCA (tumor)BRCA (normal)
MAGEA3, SUMO2, TRIM28, HTT, DNM1L (tumor)MAGEA3, SUMO2, TRIM28, HTT, DNM1L (normal)
bullet pointbullet point
COAD (tumor)COAD (normal)
MAGEA3, SUMO2, TRIM28, HTT, DNM1L (tumor)MAGEA3, SUMO2, TRIM28, HTT, DNM1L (normal)
bullet pointbullet point
HNSC (tumor)HNSC (normal)
MAGEA3, SUMO2, TRIM28, HTT, DNM1L (tumor)MAGEA3, SUMO2, TRIM28, HTT, DNM1L (normal)
bullet pointbullet point
KICH (tumor)KICH (normal)
MAGEA3, SUMO2, TRIM28, HTT, DNM1L (tumor)MAGEA3, SUMO2, TRIM28, HTT, DNM1L (normal)
bullet pointbullet point
KIRC (tumor)KIRC (normal)
MAGEA3, SUMO2, TRIM28, HTT, DNM1L (tumor)MAGEA3, SUMO2, TRIM28, HTT, DNM1L (normal)
bullet pointbullet point
KIRP (tumor)KIRP (normal)
MAGEA3, SUMO2, TRIM28, HTT, DNM1L (tumor)MAGEA3, SUMO2, TRIM28, HTT, DNM1L (normal)
bullet pointbullet point
LIHC (tumor)LIHC (normal)
MAGEA3, SUMO2, TRIM28, HTT, DNM1L (tumor)MAGEA3, SUMO2, TRIM28, HTT, DNM1L (normal)
bullet pointbullet point
LUAD (tumor)LUAD (normal)
MAGEA3, SUMO2, TRIM28, HTT, DNM1L (tumor)MAGEA3, SUMO2, TRIM28, HTT, DNM1L (normal)
bullet pointbullet point
LUSC (tumor)LUSC (normal)
MAGEA3, SUMO2, TRIM28, HTT, DNM1L (tumor)MAGEA3, SUMO2, TRIM28, HTT, DNM1L (normal)
bullet pointbullet point
PRAD (tumor)PRAD (normal)
MAGEA3, SUMO2, TRIM28, HTT, DNM1L (tumor)MAGEA3, SUMO2, TRIM28, HTT, DNM1L (normal)
bullet pointbullet point
STAD (tumor)STAD (normal)
MAGEA3, SUMO2, TRIM28, HTT, DNM1L (tumor)MAGEA3, SUMO2, TRIM28, HTT, DNM1L (normal)
bullet pointbullet point
THCA (tumor)THCA (normal)
MAGEA3, SUMO2, TRIM28, HTT, DNM1L (tumor)MAGEA3, SUMO2, TRIM28, HTT, DNM1L (normal)
bullet pointbullet point


Top
TissGeneProg for MAGEA3

check button Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image to enlarge it in a new window.
survival 1

check button Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 2

check button Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 3

check button Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 4

Top
TissGeneClin for MAGEA3
TissGeneDrug for MAGEA3

check button Drug information targeting TissGene
(DrugBank Version 5.0.6, 2017-04-01)
DrugBank IDDrug nameDrug activityDrug typeDrug status


Top
TissGeneDisease for MAGEA3

check button Disease information associated with TissGene
(DisGeNet, 2016-06-01)
Disease IDDisease name# pubmedsSource
umls:C0025202melanoma25BeFree,LHGDN
umls:C2239176Liver carcinoma9BeFree,LHGDN
umls:C0153594Malignant neoplasm of testis8BeFree
umls:C0027627Neoplasm Metastasis7BeFree
umls:C0027819Neuroblastoma4BeFree
umls:C0278883Metastatic melanoma4BeFree
umls:C0700095Central neuroblastoma4BeFree
umls:C0242379Malignant neoplasm of lung3BeFree
umls:C0007137Squamous cell carcinoma2BeFree,LHGDN
umls:C0014859Esophageal Neoplasms2BeFree
umls:C0019163Hepatitis B2BeFree
umls:C0041296Tuberculosis2BeFree
umls:C0152018Esophageal carcinoma2BeFree
umls:C0546837Malignant neoplasm of esophagus2BeFree
umls:C0005684Malignant neoplasm of urinary bladder1BeFree
umls:C0006142Malignant neoplasm of breast1BeFree
umls:C0009404Colorectal Neoplasms1LHGDN
umls:C0010674Cystic Fibrosis1BeFree
umls:C0023418leukemia1LHGDN
umls:C0023895Liver diseases1BeFree
umls:C0024121Lung Neoplasms1LHGDN
umls:C0029925Ovarian Carcinoma1BeFree
umls:C0030297Pancreatic Neoplasm1BeFree
umls:C0033578Prostatic Neoplasms1LHGDN
umls:C0036631Seminoma1BeFree
umls:C0038356Stomach Neoplasms1LHGDN
umls:C0042769Virus Diseases1BeFree
umls:C0149925Small cell carcinoma of lung1BeFree
umls:C0206701Cystadenocarcinoma, Serous1BeFree
umls:C0220656Malignant ascites1BeFree
umls:C0235974Pancreatic carcinoma1BeFree
umls:C0276199Canarypox (disorder)1BeFree
umls:C0279626Squamous cell carcinoma of esophagus1BeFree
umls:C0334471Round cell liposarcoma1BeFree
umls:C0346647Malignant neoplasm of pancreas1BeFree
umls:C0376358Malignant neoplasm of prostate1BeFree
umls:C0494165Secondary malignant neoplasm of liver1BeFree
umls:C0558356Malignant melanoma of eye1BeFree
umls:C0600139Prostate carcinoma1BeFree
umls:C0678222Breast Carcinoma1BeFree
umls:C0684249Carcinoma of lung1BeFree
umls:C0685938Malignant neoplasm of gastrointestinal tract1BeFree
umls:C0686377CNS metastases1BeFree
umls:C0699791Stomach Carcinoma1BeFree
umls:C0699885Carcinoma of bladder1BeFree
umls:C0729233Dissecting aneurysm of the thoracic aorta1BeFree
umls:C0740277Bile duct carcinoma1BeFree
umls:C1140680Malignant neoplasm of ovary1BeFree
umls:C1168401Squamous cell carcinoma of the head and neck1BeFree
umls:C1335302Pancreatic Ductal Adenocarcinoma1BeFree
umls:C1559271Non-Malignant Ascites Adverse Event1BeFree
umls:C2937421Prostatic Hyperplasia1LHGDN